Daiichi Sankyo's products treat and prevent serious illnesses as well as help people to live longer and have healthier lives. While maintaining its portfolio of marketed pharmaceuticals for hypertension and hyperlipidemia, Daiichi Sankyo is engaged in the development of treatments for thrombotic disorders and focused on the discovery of novel oncology and cardiovascular metabolic therapies.
In Europe, the dissemination of information on prescription medicines is subject to strict legal regulation. Detailed information about such subjects as the mechanism or mode of action of our products may be provided only to medical professionals. For this reason, we can give only an overview about our leading products here.
Medical professionals can obtain more detailed information on our products by contacting the Medical Services department at pharmacovigilance@daiichi-sankyo.ie or on +353 1 4893000.
For further information on our medicines please visit www.medicines.ie
DSC/22/0067 Date of prep: June 2022
